|
SNY
|
Sanofi
|
US
|
NASDAQ
|
|
TCDA
|
Tricida, Inc.
|
US
|
NASDAQ
|
|
TRIB
|
Trinity Biotech plc
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
US
|
NASDAQ
|
|
XBIO
|
Xenetic Biosciences, Inc.
|
US
|
NASDAQ
|
|
XRTX
|
XORTX Therapeutics Inc.
|
US
|
NASDAQ
|
|
ZVSA
|
ZyVersa Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AFFY
|
Affymax
|
US
|
OTC
|
|
BUHPF
|
Bumrungrad Hospital
|
US
|
OTC
|
|
ERGO
|
Entia Biosciences, Inc
|
US
|
OTC
|
|
GNHAY
|
Vifor Pharma Ag ADR
|
US
|
OTC
|
|
KHTRF
|
Knight Therapeutics
|
US
|
OTC
|
|
RTNXF
|
Renalytix Ai Plc
|
US
|
OTC
|
|
RVXCF
|
Resverlogix Corp
|
US
|
OTC
|
|
SHIEF
|
Shield Therapeutics Plc
|
US
|
OTC
|
|
RVX
|
Resverlogix Corp.
|
CA
|
TSX
|
|
XRTX
|
Xortx Therapeutics Inc
|
CA
|
TSXV
|
|
AZN
|
Astrazeneca Plc
|
UK
|
LSE
|
|
RENX
|
Renalytix Ai Plc
|
UK
|
LSE
|
|
STX
|
Shield Therapeutics Plc
|
UK
|
LSE
|